Erythropoietin / EPO抗体

Erythropoietin / EPO抗体产品信息免疫原 : Recombinant Rat Erythropoietin / EPO protein (Catalog#80055-R08B)

Antibody Type : Rabbit Polyclonal Antibody ( Antibody Purification Platform )
抗体宿主 : Rabbit IgG

缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 : Produced in rabbits immunized with purified, recombinant Rat Erythropoietin / EPO (rR Erythropoietin / EPO; Catalog#80055-R08B; P29676-1; Met 1-Arg 192). Erythropoietin / EPO specific IgG was purified by Rat Erythropoietin / EPO affinity chromatography.
Erythropoietin / EPO抗体 Background
Erythropoietin, also known as EPO, is a secreted protein which belongs to theEPO / TPO family. Erythropoietin / EPO is the principal hormone involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Erythropoietin / EPO is produced by kidney or liver of adult mammals and by liver of fetal or neonatal mammals. EPO is produced mainly by peritubular fibroblasts of the renal cortex. It is synthesized by renal peritubular cells in adults, with a small amount being produced in the liver. Erythropoietin / EPO is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine for erythrocyte (red blood cell) precursors in the bone marrow. Erythropoietin / EPO is the hormone that regulates red blood cell production. It plays an important role in the brain's response to neuronal injury. Erythropoietin / EPO is also involved in the wound healing process. Regulation is believed to rely on a feed-back mechanism measuring blood oxygenation. Erythropoietin / EPO binds to the erythropoietin receptor (EPOR) on the red cell surface and activates a JAK2 cascade. EPOR is also found in a large number of tissues such as bone marrow cells and peripheral/central nerve cells, many of which activate intracellular biological pathways upon binding with EPO. Genetic variation in EPO is associated with susceptbility to microvascular complications of diabetes type 2 (MVCD2). These are pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus.
Erythropoietin / EPO抗体相关产品如下：xy-12542R ATF5活化转录因子5抗体
xy-12543R ATF6 beta活化转录因子6β抗体
xy-12544R ATICAICAR甲酰基转移酶抗体
xy-12545R phospho-ATM (Ser794)磷酸化毛细血管扩张性共济失调症突变蛋白抗体
xy-12546R ATP5EATP5E蛋白抗体
xy-12547R ATP5G2ATP5G2蛋白抗体
xy-12548R ATP6V0D2ATP6V0D2蛋白抗体
xy-12549R ATP6V1B2ATP6V1B2蛋白抗体
xy-12550R ATPIF1ATPIF1蛋白抗体
xy-12551R AttractinAttractin蛋白抗体
xy-12552R Phospho-Aurora B(Tyr12)磷酸化有丝分裂激酶B抗体
xy-12529R ARPM1肌动蛋白相关蛋白M1抗体
xy-12565R ABH1ALKB蛋白抗体
xy-12566R ACAA1乙酰辅酶A酰基转移酶1抗体
xy-12581R phospho-beta Actin (Tyr53)磷酸化β-肌动蛋白抗体
xy-12978R phospho-beta 2 Adrenergic Receptor (Ser346)磷酸化肾上腺素能受体β2/β2-AR 抗体
xy-12979R phospho-beta 2 Adrenergic Receptor (Ser355 + Ser356)磷酸化肾上腺素能受体β2/β2-AR抗体
xy-10130R APOD载脂蛋白D抗体
xy-2586R ASIC1/BNaC2/ASIC1A酸敏感离子通道1抗体
xy-2168R ADAR1 (C-terminus)双链RNA腺苷酸脱氨基酶抗体（C端）
xy-3696R AF10髓系、淋巴、混合系白血病易位基因10抗体
xy-3681R ADCY1腺苷酸环化酶1抗体
xy-3680R APC腺瘤样息肉抗体
xy-5023R AGPAT1溶血磷脂酰基转移酶抗体
xy-9098R ANKS3锚蛋白重复及SAM结构域蛋白3抗体
xy-3047R phospho-ALK (Tyr1586)磷酸化间变型淋巴瘤激酶抗体
xy-5018R ACADVL酰基辅酶A脱氢酶很长链抗体
xy-7735R AMSH信号转导衔接结合蛋白抗体
xy-7736R ASB3锚蛋白重复序列-细胞因子信号抑制物盒蛋白家族3抗体
xy-2750R Aurora C有丝分裂激酶B抗体
xy-3045R Phospho-Ack1 (Tyr284)磷酸化Ack1抗体
xy-3046R Phospho-Ack1 (Tyr326)磷酸化Ack1抗体
xy-3048R Phospho-beta-Arrestin 1 (Ser412)磷酸化β抑制蛋白1抗体
xy-3050R Phospho-Aurora A (Thr288)磷酸化有丝分裂激酶A抗体